List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 64 studies with search of:   "Fulvestrant"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-Positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
Condition: Advanced Breast Cancer
Interventions: Drug: Dasatinib + Fulvestrant;   Drug: Fulvestrant
2 Recruiting Amgen Protocol No. 20060362 - A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Tumors;   Metastatic Cancer
Interventions: Drug: AMG 479 or placebo administered with either exemestane or fulvestrant;   Drug: AMG 479 or placebo administered with either exemestane or fulvestrant;   Drug: AMG 479 or placebo administered with either exemestane or fulvestrant
3 Completed Second Line Breast Cancer Trial
Condition: Advanced Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrozole;   Drug: Fulvestrant
4 Completed Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Fulvestrant
5 Active, not recruiting Comparison of Fulvestrant (FASLODEX™) 250 mg and 500mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
Condition: Breast Cancer
Intervention: Drug: Fulvestrant
6 Not yet recruiting Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant + ZACTIMA;   Drug: Fulvestrant + Placebo
7 Active, not recruiting Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrozole
8 Recruiting Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Arimidex with Faslodex;   Drug: Arimidex without Faslodex
9 Active, not recruiting The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Conditions: Locally Advanced Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Exemestane
10 Recruiting ZACtima FASlodex Trial
Condition: Breast Cancer
Interventions: Drug: ZD6474, VANDETANIB;   Drug: PLACEBO to MATCH ZD6474, VANDETANIB;   Drug: Fulvestrant
11 Completed Faslodex Advanced Breast Cancer Local Chinese Study
Condition: Advanced Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrozole
12 Recruiting Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: erlotinib;   Drug: Fulvestrant;   Drug: Placebo
13 Recruiting Study of Combined Fulvestrant and RAD001 in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Condition: Breast Cancer
Interventions: Drug: RAD001;   Drug: Fulvestrant
14 Active, not recruiting AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer
Condition: Advanced Breast Cancer
Interventions: Drug: AZD2171;   Drug: Fulvestrant
15 Active, not recruiting Efficacy and Safety of 500mg of Fulvestrant as a First Line Hormonal Treatment in Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Fulvestrant
16 Active, not recruiting Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
Condition: Advanced Breast Cancer
Intervention: Drug: Fulvestrant
17 Active, not recruiting Anti-Tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrazole
18 Active, not recruiting Faslodex in McCune Albright Syndrome
Conditions: Puberty, Precocious;   McCune-Albright Syndrome
Intervention: Drug: Fulvestrant
19 Active, not recruiting Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
Condition: Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrozole
20 Active, not recruiting A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
Conditions: Advanced Breast Cancer;   Metastatic Breast Cancer
Intervention: Drug: Fulvestrant

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services